Currently out of the existing stock ratings of Li Watsek, 54 are a BUY (94.74%), 3 are a HOLD (5.26%).

Li Watsek

Work Performance Price Targets & Ratings Chart

Analyst Li Watsek works at CANTOR FITZGERALD with a stock forecast success ratio of 20.24% fulfilled within 36.38 days on average.

Li Watsek’s has documented 110 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ASND, Ascendis Pharma AS at 06-Feb-2024.

Wall Street Analyst Li Watsek

Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for ONCT (ONCTERNAL THERAPEUTICS) at 9/7/2023. The price target of $1.3 was fulfilled within 123 days with a profit of $1 (333.33%) receiving and performance score of 27.1.

Average potential price target upside

CRVS Corvus Pharmaceuticals SLS Sellas Life Sciences Group AFMD Affimed NV VINC Vincerx Pharma ARVN Arvinas ASND Ascendis Pharma AS PRTG Portage Biotech ONCT Oncternal Therapeutics NKTX Nkarta  APTO Aptose Biosciences GBT Global Blood Therapeutics ALXO Alx Oncology Holdings  BCYC Bicycle Therapeutics Ltd FATE Fate Therapeutics KURA Kura Oncology RCUS Arcus Biosciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$1.65 (70.21%)

4

5 months 19 days ago

0/5 (0%)

$2.36 (143.90%)

Buy

12

$9.65 (410.64%)

4

7 months 16 days ago

1/3 (33.33%)

$9.03 (304.04%)

216

Hold

3.5

$1.15 (48.94%)

3.5

8 months 10 days ago

5/7 (71.43%)

$1.26 (56.25%)

302

Buy

8

$6.54 (447.95%)

2 years 2 months 24 days ago

0/1 (0%)

$4.69 (141.69%)

Buy

5

3 years 4 months 21 days ago

1/4 (25%)

$2.85 (132.56%)

68

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Li Watsek is most bullish on?

Potential upside of $40.36 has been obtained for BCYC (BICYCLE THERAPEUTICS LTD)

Which stock is Li Watsek is most reserved on?

Potential downside of -$7.74 has been obtained for ONCT (ONCTERNAL THERAPEUTICS)

What Year was the first public recommendation made by Li Watsek?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?